Protagonist Therapeutics (PTGX) Total Non-Current Liabilities (2015 - 2021)
Protagonist Therapeutics' (PTGX) quarterly Total Non-Current Liabilities came in at $43.4 million in Q3 2021, down 8.76% year-on-year from $47.6 million in Q3 2020, and down 7.01% quarter-over-quarter from $46.7 million in Q2 2021.
Protagonist Therapeutics (PTGX) Total Non-Current Liabilities (2015 - 2021) Analysis & Trends
Protagonist Therapeutics has disclosed Total Non-Current Liabilities across 3 years of filings, most recently posting $43.4 million for Q3 2021.
- Total Non-Current Liabilities for Q3 2021 came in at $43.4 million, down 8.76% year-over-year; the trailing twelve-month figure through Sep 2021 was $43.4 million (down 8.76% YoY), and the FY2020 annual result was $44.7 million, changed N/A from the prior year.
- Total Non-Current Liabilities came in at $43.4 million for Q3 2021 at Protagonist Therapeutics, down from $46.7 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $57.4 million in Q2 2020 to a low of $38.6 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 64.76 Mn |
| 10 | Protagonist Therapeutics | 7.35 Bn | 7.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 43.39 Mn |
| Jun 30, 2021 | 46.66 Mn |
| Mar 31, 2021 | 38.62 Mn |
| Dec 31, 2020 | 44.74 Mn |
| Sep 30, 2020 | 47.56 Mn |
| Jun 30, 2020 | 57.40 Mn |
| Dec 31, 2015 | 3.13 Mn |